Article

Obesity hypoventilation syndrome: a state-of-the-art review.

Section of Pulmonary and Critical Care Medicine, University of Chicago Pritzker School of Medicine, Chicago IL 60637, USA.
Respiratory care (Impact Factor: 1.84). 10/2010; 55(10):1347-62; discussion 1363-5.
Source: PubMed

ABSTRACT Obesity hyoventilation syndrome (OHS) is defined as the triad of obesity, daytime hypoventilation, and sleep-disordered breathing in the absence of an alternative neuromuscular, mechanical or metabolic explanation for hypoventilation. During the last 3 decades the prevalence of extreme obesity has markedly increased in the United States and other countries. With such a global epidemic of obesity, the prevalence of OHS is bound to increase. Patients with OHS have a lower quality of life, with increased healthcare expenses, and are at higher risk of developing pulmonary hypertension and early mortality, compared to eucapnic patients with sleep-disordered breathing. OHS often remains undiagnosed until late in the course of the disease. Early recognition is important, as these patients have significant morbidity and mortality. Effective treatment can lead to significant improvement in patient outcomes, underscoring the importance of early diagnosis. This review will include disease definition and epidemiology, clinical characteristics of the syndrome, pathophysiology, and morbidity and mortality associated with it. Lastly, treatment modalities will be discussed in detail.

0 Followers
 · 
276 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: To assess the prevalence, clinical characteristics, and predictors of obesity hypoventilation syndrome (OHS) in a large sample of Saudi patients with obstructive sleep apnea (OSA). This prospective observational study consisted of 1693 patients who were diagnosed to have sleep-disordered breathing using type I attended polysomnography (PSG) between January 2002 and December 2012 in the University Sleep Disorders Center (USDC) at King Saud University Hospital, Riyadh, Kingdom of Saudi Arabia. Out of 1693 OSA patients, OHS was identified in 144 (8.5%) (women 66.7%). Compared with the pure OSA patients, the OHS patients were significantly older (57.4±13.4 years versus 46.8±13.7 years), had a higher body mass index (44.6±10.8 versus 35.7±9.2 kg/m2), a higher daytime partial pressure of carbon dioxide (PaCO2) (56.5±12.7 versus 41.6±6.7 mmHg), a longer duration of nocturnal oxygen saturation (nSaO2) <90% (71.0±34.3 versus 10.5±20.5 minutes), and a higher apnea hypopnea index (68.2±47.1 versus 46.5±34.1 events/hour). A multivariate logistic regression analysis showed that serum bicarbonate (odds ratio [OR]=1.17, p=0.0001, confidence interval [CI]=1.10-1.25), and duration of nSaO2 <90% (OR=1.05, p=0.0001, CI=1.04-1.06) were predictors of OHS. Obesity hypoventilation syndrome is common among Saudi OSA patients referred to the Sleep Disorders Center. Serum bicarbonate and duration of nSaO2 <90% are independent predictors of OHS among patients with OSA.
    Saudi medical journal 02/2015; 36(2):181-9. DOI:10.15537/smj.2015.2.9991 · 0.55 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Die Diagnostik und Therapie schlafbezogener Atmungsstörungen (SBAS) unterliegt wesentlichen Veränderungen sowohl in medizinisch-wissenschaftlicher Hinsicht als auch in Bezug auf die Versorgungssituation der Patienten und sozioökonomische Aspekte. Die Relevanz der SBAS für die Morbidität und Mortalität Betroffener ist neben der besseren Differenzierung und Phänotypisierung der Untertypen der SBAS Gegenstand intensiver Forschungsaktivitäten. Diese differenzierte Betrachtung verändert die Vorgehensweise beim Verdacht auf SBAS erheblich. Dem stehen Trends zur Simplifizierung des diagnostischen Prozederes und der Therapieeinleitung, der Verlagerung medizinischer Leistungen auf nicht-medizinisches Personal und Fragen der Kostenminimierung entgegen. In diesem Konsensuspapier werden daher vor dem Hintergrund der aktuellen Situation die Prinzipien der Diagnostik, Therapieeinleitung und Versorgung, sowie die Rolle der verschiedenen Beteiligten am Gesundheitssystem und die Bewertung der Therapieangebote vorgestellt. Zu den Kernstücken gehören die Differenzierung der Diagnostik in Screening, Bestätigungsdiagnostik und Differenzialdiagnostik, der Zugang zum Patienten nach der Vortestwahrscheinlichkeit und ein therapeutischer Algorithmus. Abstract Diagnosis and treatment of sleep disordered breathing (SDB) undergo substantial changes, both in terms of increasing scientific knowledge and also in terms of patient provision and socio-economic aspects. Increasing evidence shows the relevance of SDB on morbidity and mortality of affected patients. The precise differentiation of different phenotypes of SDBs has improved substantially in recent years. These proceedings influence the approach to the patients suspected of suffering from SDB. The scientific advances on the one hand are facing intentions to simplify diagnostical processes and treatment initiation and intentions to translate duties of physicians to non-medical personnel on the other hand. This consensus paper presents the principals of diagnosis, treatment initiation and provision, including the role of different participants of the healthcare system, and compares different treatment options. Major aspects include the differentiation of the diagnostical process in screening, affirmation of diagnosis and differential diagnosis. In addition, it focusses on the relevance of the pretest probability and describes a therapeutical algorithm.
    Somnologie - Schlafforschung und Schlafmedizin 03/2014; 18(1):34-52. DOI:10.1007/s11818-013-0649-2
  • [Show abstract] [Hide abstract]
    ABSTRACT: Arterial blood gas (ABG) analysis is not a routine test in sleep laboratories due to its invasive nature. Therefore, the diagnosis of obesity hypoventilation syndrome (OHS) is underestimated. We aimed to evaluate the differences in subjects with OHS and pure obstructive sleep apnea (OSA) and to determine clinical predictors of OHS in obese subjects. Demographics, body mass index (BMI), Epworth Sleepiness Scale score, polysomnographic data, ABG, spirometric measurements, and serum bicarbonate levels were recorded. Of 152 obese subjects with OSA (79 females/73 males, mean age of 50.3 ± 10.6 y, BMI of 40.1 ± 5.6 kg/m(2), 51.9% with severe OSA), 42.1% (n = 64) had OHS. Subjects with OHS had higher BMI (P = .02), neck circumference (P < .001), waist circumference (P < .001), waist/hip ratio (P = .02), Epworth Sleepiness Scale scores (P = .036), ABG and serum bicarbonate levels (P < .001), apnea-hypopnea index (P = .01), oxygen desaturation index (P < .001), and total sleep time with SpO2 < 90% (P < .001) compared with subjects with pure OSA (n = 88). They also had lower daytime PaO2 (P < .001), sleep efficiency (P = .032), mean SpO2 (P < .001), and nadir SpO2 (P < .001) . Serum bicarbonate levels and nadir SpO2 were the only independent predictive factors for OHS. A serum bicarbonate level of ≥ 27 mmol/L as the cutoff gives a satisfactory discrimination for the diagnosis of OHS (sensitivity of 76.6%, specificity of 74.6%, positive predictive value of 54.5%, negative predictive value of 88.9%). A nadir SpO2 of < 80% as the cutoff gives a satisfactory discrimination for the diagnosis of OHS (sensitivity of 82.8%, specificity of 54.5%, positive predictive value of 56.9%, negative predictive value of 81.4%). When we used a serum bicarbonate level of ≥ 27 mmol/L and/or a nadir SpO2 of < 80% as a screening measure, only 3 of 64 subjects with OHS were missed. Serum bicarbonate level and nadir saturation were independent predictive factors for the diagnosis of OHS. Copyright © 2015 by Daedalus Enterprises Inc.
    Respiratory care 01/2015; DOI:10.4187/respcare.03733 · 1.84 Impact Factor

Preview

Download
6 Downloads
Available from